US FDA declines Moderna flu vaccine review amid vaccine guidance rollback CEO Stephane Bancel said the letter refusing review did not cite ‘any safety or efficacy concerns’.Share this: US says that it will review Moderna flu vaccine it previously declinedDateFebruary 18, 2026In relation toAl-JazeeraUW Medicine-led ovarian cancer vaccine enters phase II trial: HealthlinkDateNovember 6, 2026In relation toKing 5 NewsEbola outbreak: When will a vaccine be developed for the new strain?DateMay 21, 2026In relation toAl-Jazeera